(±)-Bisoprolol hemifumarate
Cat. No.：YN321385
CAS No. ：104344-23-2
| 产品名称: | (±)-Bisoprolol hemifumarate |
| CAS No.: | 104344-23-2 |
| Chemical Name: | 1-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-2-propanol, (2E)-2-butenedioate (2:1) |
| Synonyms: | (±)-半富马酸比索洛尔; Bisoprolol hemifumarate salt |
| 分子量: | 766.96 |
| 分子式: | C₄₀H₆₆N₂O₁₂ |
| SMILES: | OC(CNC(C)C)COC1=CC=C(COCCOC(C)C)C=C1.OC(CNC(C)C)COC2=CC=C(COCCOC(C)C)C=C2.OC(/C=C/C(O)=O)=O |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | (±)-Bisoprolol (hemifumarate) 是β1肾上腺素受体阻断剂。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Smith, C., and Teitler, M.β-blocker selectivity at cloned human β1- and β2-adrenergic receptorsCardiovasc. Drugs Ther.13(2),123-126(1999)
Mauz, A.B., and Pelzer, H.β-adrenoceptor-binding studies of the cardioselective β blockers bisoprolol, H-I 42 BS, and HX-CH 44 BS to heart membranes and intact ventricular myocytes of adult rats: Two β1-binding sites for bisoprololJ. Cardiovasc. Pharmacol.15(3),421-427(1990)
Haeusler, G., Schliep, H.-J., Schelling, P., et al.High β1-selectivity and favourable pharmacokinetics as the outstanding properties of bisoprololJ. Cardiovasc. Pharmacol.8(Suppl. 11),S2-S15(1986)
Hamed, M.I.A., Darwish, K.M., Soltane, R., et al.β-Blockers bearing hydroxyethylamine and hydroxyethylene as potential SARS-CoV-2 Mpro inhibitors: Rational based design, in silico, in vitro, and SAR studies for lead optimizationRSC Adv.11(56),35536-35558(2021)
